Development, Regulatory, & Outcomes

Member Services Networks and Communities Development, Regulatory, & Outcomes

Development, Regulatory, & Outcomes (DRO) Network

Network Goals

Enhance communication, cross-training and collaborations among members from multiple sectors including industry, government, and academia.
Apply principles of clinical pharmacology in the continuum of drug development, regulation, and post-marketing research and surveillance, as well as safe and effective utilization of medicines.

Network Connection

Upcoming Community Webinars

Check back for information about upcoming webinars.

Past Webinars

First-in-Human Starting Dose Selection: Learnings from Survey by IQ MABEL Working Group and Experiences of the Regulatory Agency

Application of Quantitative Systems Toxicology in Drug Cardiovascular Safety Assessment

Using Concentration – QTc as the Primary Analysis in TQT & Phase 1 Studies: Considerations, Methods and Case Studies; and an Introduction to Comprehensive in vitro Proarrhythmia Assessment (CiPA) initiative

Breaking Down Barriers for Acceleration of Development of New Anti-Infectives

FDA’s Sentinel System and the Regulatory Process

PBPK Modeling and Clinical Evaluation of a Natural Product-Drug Interaction

When are Transporters Important in Drug Disposition Including Tissue Distribution of Drugs?

Leadership

Anuradha Ramamoorthy, PhD
Network Chair

Jing Liu, PhD
Network Vice Chair

Robin O'Connor-Semmes, PharmD, PhD
Network Past Chair

Communities Represented

Drug Utilization & Outcomes

Early Development & Drug Safety

Global Health

Regulatory Science

Development, Regulatory, & Outcomes

Development, Regulatory, & Outcomes (DRO) Network

Description & Goals

Network Goals

Network Connection

Upcoming Community Webinars

Past Webinars

Leadership

Anuradha Ramamoorthy, PhD

Jing Liu, PhD

Robin O'Connor-Semmes, PharmD, PhD

Communities Represented